0000899243-23-002974.txt : 20230130
0000899243-23-002974.hdr.sgml : 20230130
20230130162545
ACCESSION NUMBER: 0000899243-23-002974
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230126
FILED AS OF DATE: 20230130
DATE AS OF CHANGE: 20230130
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Osborne William H
CENTRAL INDEX KEY: 0001445187
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36847
FILM NUMBER: 23568123
MAIL ADDRESS:
STREET 1: 1415 WEST 22ND STREET
STREET 2: SUITE 1100
CITY: OAK BROOK
STATE: IL
ZIP: 60523
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Invitae Corp
CENTRAL INDEX KEY: 0001501134
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MEDICAL LABORATORIES [8071]
IRS NUMBER: 271701898
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 1400 16TH STREET
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94103
BUSINESS PHONE: (415) 374-7782
MAIL ADDRESS:
STREET 1: 1400 16TH STREET
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94103
FORMER COMPANY:
FORMER CONFORMED NAME: InVitae Corp
DATE OF NAME CHANGE: 20121105
FORMER COMPANY:
FORMER CONFORMED NAME: Locus Development Inc
DATE OF NAME CHANGE: 20100910
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2023-01-26
0
0001501134
Invitae Corp
NVTA
0001445187
Osborne William H
C/O INVITAE CORPORATION
1400 16TH STREET
SAN FRANCISCO
CA
94103
1
0
0
0
Common Stock
2023-01-26
4
A
0
70423
0.00
A
70423
D
Stock Option (right to buy)
2.46
2023-01-26
4
A
0
28902
0.00
A
2033-01-26
Common Stock
28902
28902
D
Shares issuable upon settlement of a restricted stock unit award that vests in four equal installments, with 1/4th of the total award vesting on each of February 15, 2024, 2025, 2026 and 2027, subject to continued service with the Issuer through the applicable vesting dates.
Includes 70,423 shares of common stock issuable pursuant to restricted stock units that have not vested.
Options vests over four years as follows: 25% of the shares vest on January 26, 2024, and 1/48th of the shares vest each month thereafter for the remaining three years, subject to continued service with the Issuer through the applicable vesting dates.
/s/ Thomas R. Brida, Attorney-in-Fact
2023-01-30